Montelucaste Sandoz (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1 on airway smooth muscle and inflammatory cells. This inhibition prevents leukotriene D4 and related mediators from causing bronchoconstriction, mucus production, and vascular leakage, thereby reducing airway inflammation and hyper‑responsiveness.

The appropriate dose of Montelucaste Sandoz is determined by the prescribing healthcare professional based on the patient’s age, condition, and response to therapy. Dosage forms and strengths are selected to match the clinician’s recommendation; patients should follow the prescribed regimen exactly.

Safety of montelukast during pregnancy or lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and discuss any concerns with the patient. If used while breastfeeding, monitoring the infant for adverse effects is advisable.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients who prefer a tablet, have difficulty using inhalers, or need additional control of allergic rhinitis. Clinical guidelines often recommend it as add‑on therapy rather than a sole replacement for inhaled steroids.

Montelucaste Sandoz tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in high‑humidity environments such as bathrooms.

The medication is taken orally, usually once daily in the evening, with or without food as directed by the prescriber. Swallow the tablet whole; do not crush, chew, or split unless specifically instructed.

Serious risks, though rare, include severe allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric events like depression, anxiety, or suicidal thoughts. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelucaste Sandoz should be avoided in individuals with known hypersensitivity to montelukast or any component of the formulation. It is also not suitable for acute asthma attacks; patients experiencing sudden breathing difficulty should use a rescue inhaler instead of this medication.